News

Exciting Updates on Hargreave Hale AIM VCT PLC's NAV

Exciting Updates on Hargreave Hale AIM VCT PLC's NAV

Understanding Hargreave Hale AIM VCT PLC's NAV

Hargreave Hale AIM VCT PLC, affectionately referred to as the Company, is focused on enhancing shareholder value through effective investment strategies. As part of their commitment to transparency, the Company publishes its Net Asset Value (NAV) regularly. This document serves to provide shareholders and interested parties with updates on the Company's financial health.

Recent NAV Announcement

On January 24, 2025, Hargreave Hale AIM VCT PLC announced its unaudited NAV, an important indicator reflecting the value of the Company's assets. At the close of business on that date, the NAV per Ordinary share of 1p Cum Dividend stood at an impressive 40.29 pence. This figure accounts for all financial aspects, including dividends that have yet to be declared.

Cum and Ex-Dividend NAVs Explained

In addition to the Cum Dividend figure, the Ex-Dividend NAV was reported at 37.54 pence. The distinction between these two values is crucial for shareholders. The Cum Dividend NAV includes anticipated future dividends, while the Ex-Dividend reflects the share value without those expected dividends. Understanding these values helps investors make informed decisions.

Key Contact Information

For those seeking to dive deeper into the specifics of Hargreave Hale AIM VCT PLC's operations or require further information regarding the NAV, the Company offers accessible communication channels. Stakeholders are encouraged to reach out directly.

Get In Touch

Contact JTC (UK) Limited for any inquiries related to the Company’s NAV and overall performance. The statements from representatives Uloma Adighibe and Alexandria Tivey can provide you with guidance and insights into the Company’s strategy and shareholder benefits. The contact details available for further correspondence are as follows:

Email: HHV.CoSec@jtcgroup.com
Phone: +44 203 832 3877
Alternative Phone: +44 203 832 3891

LEI Code and Compliance

The Legal Entity Identifier (LEI) for Hargreave Hale AIM VCT PLC is 213800LRYA19A69SIT31. This code is essential for transparency in financial markets, ensuring that institutions and investors can easily identify the Company in their dealings.

Conclusion

In summary, Hargreave Hale AIM VCT PLC remains dedicated to delivering value to its shareholders. The recent NAV announcements highlight its commitment to transparency and shareholder engagement. Investors are encouraged to stay informed about future updates and reach out with any questions or concerns.

Frequently Asked Questions

What is the significance of the NAV announcement?

The NAV announcement reflects the financial standing of Hargreave Hale AIM VCT PLC, providing insights into its asset value and shareholder equity.

How can I understand Cum and Ex-Dividend NAV?

The Cum Dividend NAV includes future dividends, whereas the Ex-Dividend NAV is the share price without considering upcoming dividends. It is crucial for making investment decisions.

Who can I contact for more information?

You can contact JTC (UK) Limited, specifically representatives Uloma Adighibe and Alexandria Tivey, for inquiries regarding Hargreave Hale AIM VCT PLC.

What is the significance of the LEI code?

The LEI code helps identify the Company in financial transactions, ensuring transparency and compliance in the financial markets.

How often does Hargreave Hale AIM VCT PLC announce its NAV?

The Company regularly updates its NAV to keep shareholders informed about financial performance and asset value.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Super Hi Reports Strong Q2 2024 Financial Results

Updated Category News Views 223

Super Hi Reports Impressive Q2 2024 Financial Results Super Hi International Holding Ltd. (NASDAQ: HDL and HKEX: 9658), a prominent brand in Chinese cuisine known for its Haidilao hot pot restaurants worldwide, has announced its unaudited financial results for the second quarter of FY2024, which ended on June 30, 2024. Financial Highlights for Q2 2024 The company's...

Continue Reading
BEN Expands AI Reach with $1M Accelevate Stake

Updated Category News Views 4

A Strategic Move with a Million-Dollar Stake What do you call a million bucks invested in a company called Accelevate? Well, Brand Engagement Network, Inc. (NASDAQ: BNAI) seems to think it's just good business sense. They've tossed a cool million at Accelevate Solutions, snagging themselves about 10% ownership straight off the bat. Let me tell you, when folks throw around...

Continue Reading
Vasa Therapeutics Accelerates Heart Failure Treatment with VS-041

Updated Category News Views 266

Vasa Therapeutics Receives FDA Fast Track Designation for VS-041 Vasa Therapeutics, a biopharmaceutical company focused on innovative therapies for cardiovascular issues, is making significant strides with its lead investigational drug, VS-041. Recently, the FDA granted Fast Track designation for this unique treatment aimed at addressing heart failure with preserved...

Continue Reading
Legal Action Launched for Acadia Healthcare Investors Amid Concerns

Updated Category News Views 52

Introduction to the Class Action Lawsuit The Law Offices of Frank R. Cruz has initiated a class action lawsuit on behalf of investors of Acadia Healthcare Company Inc. (NASDAQ: ACHC). This legal motion concerns individuals and entities who purchased or acquired Acadia securities during a specified period. The lawsuit is rooted in serious allegations regarding the...

Continue Reading
Linux Foundation Launches Akrites for Open Source Security

Updated Category News Views 18

The Battle Against AI-Driven Vulnerabilities Alright, let's dive into this. These days, open source software is the backbone holding up pretty much every industry out there. Banking, healthcare, energy—you name it, it's running on it. But here's the kicker: AI's making it a heck of a lot easier for the bad guys to find holes in it. The Linux Foundation just christened...

Continue Reading